FA
AEHR icon

Friess Associates’s Aehr Test Systems AEHR Stock Holding History

Friess Associates’s Portfolio AEHR Stock Details AEHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$1.91M Buy
255,208
+50,000
+24% +$415K 3.19% 16
2022
Q1 		$2.08M Buy
205,208
+28,208
+16% +$361K 1.11% 43
2021
Q4 		$4.28M Buy
+177,000
New +$3.46M 1.67% 21

Other funds holding AEHR

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAS
Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Friess Associates's AEHR Position: Q2 2022 in Review

Friess Associates increased its Aehr Test Systems (AEHR) stake by 24% in Q2 2022, buying an estimated $415K and bringing the position to 255,208 shares worth $1.91M. The position accounts for 3.19% of the portfolio, ranked #16.

Friess Associates first reported a position in AEHR in Q4 2021 and has held it in 3 quarters since. The position peaked at $4.28M in Q4 2021. 70 funds tracked by Wall St. Rank hold AEHR as of Q2 2022.

  • Friess Associates held 255,208 shares of Aehr Test Systems worth $1.91M as of Q2 2022.
  • Friess Associates bought 50,000 Aehr Test Systems shares in Q2 2022, an estimated $415K.
  • Aehr Test Systems made up 3.19% of Friess Associates's portfolio in Q2 2022, its #16 holding.
  • Friess Associates first reported a position in Aehr Test Systems in Q4 2021 and has held it in 3 quarters since.
  • Friess Associates's Aehr Test Systems position peaked at $4.28M in Q4 2021.
  • 70 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2022.

Based on Friess Associates's 13F filing for Q2 2022, filed 15 Aug 2022.